Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia
With vaccine uptake similar to that achieved for other maternal vaccines in Australia, a year-round RSV maternal vaccination program is predicted to approximately halve the number of RSV hospitalisations in infants younger than 6 months. There was a small herd effect predicted in the base case but potential for larger benefits if vaccine coverage or the duration of protection exceeds base case assumptions.
Authors
- James Wood (ORCID: https://orcid.org/0000-0002-0122-4482)
- Allen L. Nazareno (ORCID: https://orcid.org/0000-0002-8969-6774)
- Anthony T. Newall (ORCID: https://orcid.org/0000-0003-0836-1065)
- Alexandra B. Hogan (ORCID: https://orcid.org/0000-0002-6271-9921)
- David Muscatello (ORCID: https://orcid.org/0000-0002-2391-4396)
Institutions
- University of the Philippines Los Baños (PH)
- UNSW Sydney (AU)
Publication Details
- Journal
- Vaccine
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1016/j.vaccine.2024.126418
- Citations
- 8
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 3.09
Funders
- National Health and Medical Research Council